Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Genetically Engineered Animals
Knockout Mice
Knockout Rats
Knockin Mice
Knockin Rats
Transgenic Mice
Transgenic Rats
Model Generation Techniques
Turboknockout<sup>®</sup> Gene Targeting
ES Cell Gene Targeting
Targeted Gene Editing
Regular Transgenic
PiggyBac Transgenesis
BAC Transgenic
Research Models
HUGO-GT™ Humanized Mice
Cre Mouse Lines
Humanized Target Gene Models
Metabolic Disease Models
Ophthalmic Disease Models
Neurological Disease Models
Autoimmune Disease Models
Immunodeficient Mouse Models
Humanized Immune System Mouse Models
Oncology & Immuno-oncology Models
Covid-19 Mouse Models
MouseAtlas Model Library
Knockout Cell Line Product Catalog
Tumor Cell Line Product Catalog
AAV Standard Product Catalog
Animal Supporting Services
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
BAC Modification
Custom Cell Line Models
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Point Mutation Cell Lines
Overexpression Cell Lines
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Lentivirus Packaging
Adenovirus Packaging
CRO Services
By Therapeutic Area
Oncology
Ophthalmology
Neuroscience
Metabolic & Cardiovascular Diseases
Autoimmune & Inflammatory
By Drug Type
AI-Powered AAV Discovery
Gene Therapy
Oligonucleotide Therapy
Antibody Therapy
Cell Immunotherapy
Resources
Promotion
Events & Webinars
Newsroom
Blogs & Insights
Resource Vault
Reference Databases
Peer-Reviewed Citations
Rare Disease Data Center
AbSeek
Cell iGeneEditor™ System
OriCell
Quality
Facility Overview
Animal Health & Welfare
Health Reports
About Us
Corporate Overview
Our Partners
Careers
Contact Us
Login
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
Organization
Job Role
Country
Catalog Type
Product Name
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
C57BL/6JCya-Inpp5dem1/Cya
Common Name:
Inpp5d-KO
Product ID:
S-KO-16385
Background:
C57BL/6JCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Inpp5d-KO
Strain ID
KOCMP-16331-Inpp5d-B6J-VA
Gene Name
Inpp5d
Product ID
S-KO-16385
Gene Alias
SHIP; SHIP-1; SHIP1; SIP-145; p150Ship; s-SHIP
Background
C57BL/6JCya
NCBI ID
16331
Modification
Conventional knockout
Chromosome
1
Phenotype
MGI:107357
Document
Click here to download >>
Application
--
More
Rare Disease Data Center >>
Note
Note: When using this mouse strain in a publication, please cite “C57BL/6JCya-Inpp5dem1/Cya mice (Catalog S-KO-16385) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000169754
NCBI RefSeq
NM_010566
Target Region
Exon 10~17
Size of Effective Region
~11.6 kb
Detailed Document
Click here to download >>
Overview of Gene Research
Inpp5d, also known as Inositol polyphosphate-5-phosphatase D, encodes a dual-specificity phosphatase that can dephosphorylate both phospholipids and phosphoproteins. It is a myeloid-expressed gene, and its protein product SHIP1 is an important regulator in microglial phagocytosis, immune response, and phosphoinositide signaling. The NLRP3 inflammasome signaling is one of the associated pathways, and Inpp5d is genetically associated with Alzheimer's disease (AD), highlighting its significance in neurodegenerative disease research [1,2,3,4,5,6,7,8,9,10].

In Inpp5d-deficient mouse models, several important findings have emerged. In the PSAPP mouse model, conditional Inpp5d down-regulation increased plaque burden and the recruitment of microglia to plaques [2]. In the 5xFAD mouse model, Inpp5d haplodeficiency enhanced microglial functions by increasing plaque clearance and preserved cognitive abilities [6]. In the PS19 mouse model of Tauopathy, Inpp5d haplodeficiency alleviated tau pathology and motor deficits [7]. Also, loss of Inpp5d in wild-type mice had sex-specific effects on the brain transcriptome, with affected genes enriched for multiple neurodegeneration terms [8]. In 5xFAD Inpp5dfl/fl Cx3cr1Ert2Cre mice, SHIP-1 deletion in microglia led to enhanced microglial recruitment to Aβ plaques, improved neuronal health, and enhanced plaque containment and Aβ engulfment [10].

In conclusion, Inpp5d is a crucial regulator in microglial-mediated processes, especially in the context of AD-related pathology. Mouse models, including KO/CKO models, have been instrumental in revealing its role in plaque formation, microglial function, and cognitive preservation in AD, as well as in tau pathology. These findings offer potential therapeutic strategies targeting Inpp5d for neurodegenerative diseases.

References:

1. Chou, Vicky, Pearse, Richard V, Aylward, Aimee J, Menon, Vilas, Young-Pearse, Tracy L. 2023. INPP5D regulates inflammasome activation in human microglia. In Nature communications, 14, 7552. doi:10.1038/s41467-023-42819-w. https://pubmed.ncbi.nlm.nih.gov/38016942/

2. Castranio, Emilie L, Hasel, Philip, Haure-Mirande, Jean-Vianney, Liddelow, Shane A, Ehrlich, Michelle E. 2022. Microglial INPP5D limits plaque formation and glial reactivity in the PSAPP mouse model of Alzheimer's disease. In Alzheimer's & dementia : the journal of the Alzheimer's Association, 19, 2239-2252. doi:10.1002/alz.12821. https://pubmed.ncbi.nlm.nih.gov/36448627/

3. Terzioglu, Gizem, Young-Pearse, Tracy L. 2023. Microglial function, INPP5D/SHIP1 signaling, and NLRP3 inflammasome activation: implications for Alzheimer's disease. In Molecular neurodegeneration, 18, 89. doi:10.1186/s13024-023-00674-9. https://pubmed.ncbi.nlm.nih.gov/38017562/

4. Olufunmilayo, Edward O, Holsinger, R M Damian. 2023. INPP5D/SHIP1: Expression, Regulation and Roles in Alzheimer's Disease Pathophysiology. In Genes, 14, . doi:10.3390/genes14101845. https://pubmed.ncbi.nlm.nih.gov/37895194/

5. Chou, Vicky, Fancher, Seeley B, Pearse, Richard V, Menon, Vilas, Young-Pearse, Tracy L. 2023. INPP5D/SHIP1 regulates inflammasome activation in human microglia. In bioRxiv : the preprint server for biology, , . doi:10.1101/2023.02.25.530025. https://pubmed.ncbi.nlm.nih.gov/36865139/

6. Lin, Peter Bor-Chian, Tsai, Andy Po-Yi, Soni, Disha, Lamb, Bruce T, Oblak, Adrian L. 2022. INPP5D deficiency attenuates amyloid pathology in a mouse model of Alzheimer's disease. In Alzheimer's & dementia : the journal of the Alzheimer's Association, 19, 2528-2537. doi:10.1002/alz.12849. https://pubmed.ncbi.nlm.nih.gov/36524682/

7. Soni, Disha M, Lin, Peter Bor-Chian, Lee-Gosselin, Audrey, Chu, Shaoyou, Oblak, Adrian L. 2024. Inpp5d haplodeficiency alleviates tau pathology in the PS19 mouse model of Tauopathy. In Alzheimer's & dementia : the journal of the Alzheimer's Association, 20, 4985-4998. doi:10.1002/alz.14078. https://pubmed.ncbi.nlm.nih.gov/38923171/

8. Dabin, Luke C, Kersey, Holly, Kim, Byungwook, Lamb, Bruce T, Kim, Jungsu. 2024. Loss of Inpp5d has disease-relevant and sex-specific effects on glial transcriptomes. In Alzheimer's & dementia : the journal of the Alzheimer's Association, 20, 5311-5323. doi:10.1002/alz.13901. https://pubmed.ncbi.nlm.nih.gov/38923164/

9. Karch, Celeste M, Goate, Alison M. 2014. Alzheimer's disease risk genes and mechanisms of disease pathogenesis. In Biological psychiatry, 77, 43-51. doi:10.1016/j.biopsych.2014.05.006. https://pubmed.ncbi.nlm.nih.gov/24951455/

10. Samuels, Joshua D, Moore, Katelyn A, Ennerfelt, Hannah E, Price, Richard J, Lukens, John R. 2023. The Alzheimer's disease risk factor INPP5D restricts neuroprotective microglial responses in amyloid beta-mediated pathology. In Alzheimer's & dementia : the journal of the Alzheimer's Association, 19, 4908-4921. doi:10.1002/alz.13089. https://pubmed.ncbi.nlm.nih.gov/37061460/

Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0338
Email:
animal-service@cyagen.com
service@cyagen.us
CRO Services
OncologyOphthalmologyNeuroscienceMetabolic & CardiovascularAutoimmune & InflammatoryGene TherapyAntibody Therapy
About Us
Corporate OverviewOur PartnersCareersContact Us
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest